Tuberculosis (TB) remains to be a major infectious disease throughout the world. However, the current vaccine for TB has variable protective efficacy, and there is no commercially available serodiagno

NIAID Data Ecosystem30

Features and protective efficacy of human monoclonal antibodies targeting M. tuberculosis arabinomannan. Features and protective efficacy of human monoclonal antibodies targeting M. tuberculosis arabinomannan

结核病基因与分子

抗原表位分析

Human antibody responses to AM/LAM are heterogenous and knowledge of reactivity to specific glycan epitopes at the monoclonal level is limited. Using novel glycan arrays, we characterized a very high

NIAID Data Ecosystem30

Antigen 85C with octylthioglucoside in active site

蛋白质-配体相互作用

结核病基因与分子

Antigen 85C with octylthioglucoside in active site

NIAID Data Ecosystem30